GI
IBB icon

GAMMA Investing’s iShares Biotechnology ETF IBB Stock Holding History

GAMMA Investing’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$140K Hold
667
– – ﹤0.01% 1599
2026
Q2 		$127K Hold
667
– – ﹤0.01% 1632
2026
Q1 		$113K Buy
667
+329
+97% +$56.3K 0.01% 1576
2025
Q4 		$57.1K Hold
338
– – ﹤0.01% 1984
2025
Q3 		$48.8K Sell
338
-39
-10% -$5.32K ﹤0.01% 2009
2025
Q2 		$47.7K Hold
377
– – ﹤0.01% 1972
2025
Q1 		$48.3K Hold
377
– – ﹤0.01% 1815
2024
Q4 		$49.9K Hold
377
– – ﹤0.01% 1662
2024
Q3 		$54.9K Hold
377
– – 0.01% 1424
2024
Q2 		$51.8K Hold
377
– – 0.01% 1172
2024
Q1 		$51.8K Hold
377
– – 0.01% 1029
2023
Q4 		$50.7K Buy
+377
New +$46K 0.01% 890

Other funds holding IBB

AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
CCA
Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
KIG
Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return

GAMMA Investing's IBB Position: Q3 2026 in Review

GAMMA Investing held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 667 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

GAMMA Investing first reported a position in IBB in Q4 2023 and has held it in 12 quarters since. 40 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • GAMMA Investing held 667 shares of iShares Biotechnology ETF worth $140K as of Q3 2026.
  • GAMMA Investing left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1599 holding.
  • GAMMA Investing first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 12 quarters since.
  • 40 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.